Skip to content
★ Sign in to follow
FE

Fabrice Egros

Board Director
Director
Total declarations
16
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (7 ops.)
€847k

Latest filing published 03 Feb 2022 for Syndax Pharmaceuticals Inc.

Filing timeline

BuySale
Fabrice Egros

Insider track record

Disclosed buys
0
Disclosed sells
7
Signal history

Fabrice Egros: trading record in brief

All filings by Fabrice Egros on record concern Syndax Pharmaceuticals Inc, in the capacity of board member. Between 3 February 2021 and 2 February 2022, the trades on record add up to 16 filings.

On the market, this insider has only sold: 7 sales, €847k in total. Besides market trades, the filings include 2 share grants and 7 option exercises.

The record was last updated on 3 February 2022 with a share grant in Syndax Pharmaceuticals Inc. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Fabrice Egros

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations16 total

16 of 16 declarations